George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 1.00 (1.77%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 57.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

16 Jun 2023 12:00

RNS Number : 0282D
British Smaller Companies VCT2 Plc
16 June 2023
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2023

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 31 March 2023, the Company generated a 1.0 per cent return on its opening Net Asset Value of 61.6 pence, compared to a 1.9 per cent fall in the FTSE Small Cap. AIC data ranks the Company second across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5 and 10 years.

The Company's Total Return at 31 March 2023 was up 0.6 pence at 143.2 pence per ordinary share.

During the quarter, the Company invested £2.4 million into new investment DrDoctor, a patient engagement and communications software platform; and £1.2 million into new investment Xapien, an AI-powered software platform that fully automates detailed background research on individuals and companies. The Company has also invested a further £1.6 million into Quality Clouds, to provide the runway and resources to accelerate the company's sales growth.

Following the quarter end, one follow-on investment totalling £0.5 million into Relative Insight has been completed, taking the total invested in the current financial year to £5.7 million, following the £16.3 million invested in 2022.

The Company realised its investment in Wakefield Acoustics in January 2023, generating proceeds of £0.6 million and an overall return of 1.5x cost. Subsequent to the quarter end, the Company realised its investment in Ncam, in line with the valuation at 31 March 2023, with initial proceeds of £0.9 million being received.

 

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

31 December 2022

Increase in Value

Dividends paid/shares issued

Buyback of shares

Movement

in Period

31 March 2023

Net Assets (£m)

111.9

1.0

(3.3)

(0.3)

(2.6)

109.3

NAV per share (PPS)

61.6p

0.6p

(2.25p)

-

(1.65p)

59.95p

Cumulative dividends paid (PPS)

81.0p

-

2.25p

-

-

83.25p

Total Return (PPS)

142.6p

0.6p

-

-

0.6p

143.2p

Shares in issue

181,468,710

-

1,427,418

(552,351)

875,067

182,343,777

The unaudited NAV per ordinary share was down 1.65 pence at 59.95 pence per share (31 December 2022: 61.6 pence per ordinary share), following the dividend of 2.25 pence per share paid on 11 January 2023.

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 December 2022

111.9

61.6

Increase in portfolio value

1.5

0.8

Net operating costs

(0.5)

(0.2)

1.0

0.6

Issue/buy-back of shares

0.5

-

Total Return in the period

1.5

0.6

NAV before the payment of dividends

113.4

62.2

Dividends paid

(4.1)

(2.25)

NAV at 31 March 2023

 

109.3

 

59.95

Buybacks, dividends and shares in issue

On 28 March 2023, the Company purchased 552,351 ordinary shares of 10 pence each at a price of 56.88 pence per ordinary share. These shares were placed in treasury.

Following payment of the special dividend for the year ending 31 December 2023 of 2.25 pence per ordinary share on 11 January 2023, the Company issued 1,427,418 ordinary shares under the DRIS, taking cumulative dividends paid to 83.25 pence per ordinary share.

The number of ordinary shares in issue at 31 March 2023 was 182,343,777 (31 December 2022: 181,468,710). In addition, at 31 March 2023 the Company held 19,219,163 ordinary shares in treasury (31 December 2022: 18,666,812).

Following the successful fundraising, the Company issued 46,357,328 ordinary shares of 10 pence each on 4 April 2023, taking the number of shares in issue to 228,701,105 ordinary shares with voting rights.

The Board has approved an interim dividend of 1.5 pence per ordinary share for the year ending 31 December 2023, which will be paid on 26 June 2023 to those shareholders on the Company's register at the close of business on 12 May 2023.

Net assets

Net assets at 31 March 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

87,428

80.0

Listed investment funds

1,504

1.4

Cash and cash equivalents

19,993

18.3

Other net current assets

383

0.3

Net assets

109,308

100.0

 

Investments

The investment portfolio at 31 March 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

21,281

19.5%

Unbiased

6,652

25.6%

Outpost

6,280

31.3%

Wooshii

4,761

35.7%

Displayplan

4,254

39.5%

Elucidat

4,184

43.4%

ACC Aviation

3,614

46.7%

Force24

3,172

49.6%

Quality Clouds

2,716

52.1%

Vypr

2,701

54.5%

59,615

54.5%

Other investments

27,813

80.0%

Total investments

87,428

80.0%

Shareholder relations

An in-person Shareholder Workshop will be held on Tuesday 2o June 2023 at 1 Great George Street, Westminster, London SW1P 3AA. Please email Tracey Nice at Tracey.nice@yfmep.com for further information.

Fundraising

On 4 April 2023, the Company allotted shares from its fully subscribed 2022/23 share offer. £27.5 million was raised by the Company, resulting in the allotment of 46,357,328 ordinary shares. This increased the number of ordinary shares issued with voting rights to 228,701,105.

Outlook

The economic environment remains challenging; while energy prices and inflation are moving down from peaks, these remain high, keeping interest rates elevated. This has fed through to valuation multiples, which remain dampened. In this environment, the portfolio continues to be robust, with the Company's performance buoyed by positive uplifts when exiting investments and continued revenue growth from existing investments.

There continues to be a good pipeline of new companies seeking investment, and the opportunity to deploy funds into existing portfolio companies to help them accelerate their growth.

The Board thanks new and existing shareholders for their support in the recent fundraising and look forward to updating shareholders on progress deploying these funds over the coming quarters.

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

16 June 2023

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFGPUWPQUPWGUQ
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.